# Mitsubishi Tanabe Pharma Development America, Inc., Jersey City, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/mitsubishi-tanabe-pharma-development-america-inc/f5e77e46-b625-4cdd-a44a-ecd7583b6baa

> Inspection records and compliance data for Mitsubishi Tanabe Pharma Development America, Inc. in Jersey City, New Jersey. 3 FDA inspections on record, last inspected September 18, 2025.

---

## Details

- Name: Mitsubishi Tanabe Pharma Development America, Inc.
- FEI Number: 3003777563
- Address Line 1: 525 Washington Blvd Ste 400
- City: Jersey City
- State: New Jersey
- Zip Code: 07310
- Country Name: United States
- Address: 525 Washington Blvd Ste 400, Jersey City, New Jersey 07310, United States
- Country: United States

## Related Documents

- [FDA Inspection 1298296 - Mitsubishi Tanabe Pharma Development America, Inc. - 2025-09-18](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/dceb2a25-e1ea-4e5b-a250-2f0f9fccf476) — source: FDA, date: September 18, 2025
- FDA Inspection 1298296 - Mitsubishi Tanabe Pharma Development America, Inc. - 2025-09-18 — classification: No Action Indicated (NAI), source: FDA, date: September 18, 2025
- [EIR - Mitsubishi Tanabe Pharma Development America, Inc. - 2021-10-15](https://www.keypedia.com/records/eir/mitsubishi-tanabe-pharma-development-america-inc/19ffbcc4-6b27-4aa3-b823-6f7e213b87c1) — source: FDA, date: October 15, 2021
- [483 - Mitsubishi Tanabe Pharma Development America, Inc. - 2021-10-15](https://www.keypedia.com/records/483/mitsubishi-tanabe-pharma-development-america-inc/40f73b79-76f1-4878-a034-b697a60dcaaa) — source: FDA, date: October 15, 2021
- [FDA Inspection 1155136 - Mitsubishi Tanabe Pharma Development America, Inc. - 2021-10-15](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/f7044b8b-5d0a-4038-b5b4-93419bd38f76) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2021
- [FDA Inspection 857641 - Mitsubishi Tanabe Pharma Development America, Inc. - 2013-12-04](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/24eb30a9-ccc6-44e7-bcfa-9e1a8da6556c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2013

## Related Companies

- [Validus Pharmaceuticals, Inc.](https://www.keypedia.com/companies/validus-pharmaceuticals-inc/4fc18f5f-2ae4-4655-8277-eb94af507596)
- [Aurohealth LLC](https://www.keypedia.com/companies/aurohealth-llc/c20201d7-26bf-46b9-8284-91b7caa49ba7)
- [Nimesh P. Nagarsheth, M.D.](https://www.keypedia.com/companies/nimesh-p-nagarsheth-md/a78321b6-77d9-4cb3-9c7f-62286a03223b)
- [Gregory J. Tracey, M.D.](https://www.keypedia.com/companies/gregory-j-tracey-md/82565cdf-eeff-40d7-8619-804215da3268)
- [Wockhardt USA LLC](https://www.keypedia.com/companies/wockhardt-usa-llc/014f1eef-1611-4235-9b43-ed9633b04f33)
- [Unipack LLC](https://www.keypedia.com/companies/unipack-llc/31b9e50c-e551-4f7c-a6bc-c52197dcb7c5)
- [Haisco-USA Pharmaceuticals, Inc.](https://www.keypedia.com/companies/haisco-usa-pharmaceuticals-inc/841bf104-d213-438a-8459-628b7a236b1a)
- [PharMEDium Services LLC](https://www.keypedia.com/companies/pharmedium-services-llc/d6b93694-93ea-4852-b10b-06e30501e380)
- [Aucta Pharmaceuticals, Inc.](https://www.keypedia.com/companies/aucta-pharmaceuticals-inc/059c06e7-55b6-4f92-b6c5-5702c3ff16e3)
- [Monmouth Medical Center IRB](https://www.keypedia.com/companies/monmouth-medical-center-irb/dae624eb-9970-4faa-9e1f-763327df8899)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)
- [investigator](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)
